A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system

Published:2023-08-24 Issue:11 Volume:22 Page:1133-1142
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Wen Haixiao¹,Lu Chong²,Zhang Meng²,Qi Xingling²

Affiliation:

1. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

2. Department of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

Funder

Shanghai Health Commission

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2247971

Reference37 articles.

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use

2. The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey

3. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women

4. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause

5. Non-hormonal treatments for managing vulvovaginal atrophy/genitourinary syndrome of menopause

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP